@article{article, title  = {{Comparative study of neoadjuvant chemotherapy with and without Zometa for management of locally advanced breast cancer with serum VEGF as primary endpoint: The NEOZOL study}},

 publisher = {{Elsevier}},

 url = {{http://eprints.whiterose.ac.uk/152917/ }},

 year = {{2018}},

 month = {{12}},

 author = {{Lelièvre L and Clézardin P and Magaud L and Roche L and Tubiana-Mathieu N and Tigaud J-D and Topart D and Raban N and Mouret-Reynier M-A and Mathevet P}},

 doi = {{10.1016/j.clbc.2018.07.005}},

 volume = {{18}},

 journal = {{Clinical Breast Cancer}},

 issue = {{6}},

 pages = {{e1311-e1321}},

 note = {{Accessed on 2025/10/26}}}